Promedica International Cme entered the industry of Medical Research in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of Unknown. The NAICS classifies this business under the code 8132120, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Judie Vivian by calling (760) 720-2263 during business hours. You can also write to the business’ Single Location at 2333 State St # 203, Carlsbad, California CA 92008. You can also visit the company’s website at promedicacme.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Promedica International Cme |
| Representative: | Judie Vivian |
| Place of Business: | 2333 State St # 203, Carlsbad, CA 92008 |
| Contact Number: | (760) 720-2263 |
| Website: | promedicacme.com |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 8132120 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2004 |
| Income/Year: | Unknown |
| Laborers: | 1 to 4 |
| Share This Company: |
Promedica International Cme is a company operating from San Diego, California providing professional Medical Research and relevant B2B variables. It was founded in 2004 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 8132120 as Medical Research.
With a current employee count of 1 to 4, Promedica International Cme has gone to report making Unknown per annum on its journey towards growth. This company invites you to contact its representative Judie Vivian at (760) 720-2263 for related queries, or to locate its Single Location using the coordinates 33.16523,-117.35363.
The Single Location can also be found at the street address 2333 State St # 203 in Carlsbad, California 92008 and can be engaged online through the company website at promedicacme.com, the company Twitter , and Facebook page .